nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—HSD3B2—Mineralocorticoid biosynthesis—CGA—conduct disorder	0.41	0.424	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Androgen biosynthesis—CGA—conduct disorder	0.253	0.261	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.105	0.108	CbGpPWpGaD
Medroxyprogesterone Acetate—Testosterone Propionate—COMT—conduct disorder	0.0233	0.753	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—CGA—conduct disorder	0.0114	0.0118	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0108	0.0111	CbGpPWpGaD
Medroxyprogesterone Acetate—Testosterone—MAOA—conduct disorder	0.00764	0.247	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—Metapathway biotransformation—COMT—conduct disorder	0.00616	0.00636	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00573	0.00592	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00535	0.00553	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00531	0.00548	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CGA—conduct disorder	0.00479	0.00494	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—FOXA1 transcription factor network—EP300—conduct disorder	0.00479	0.00494	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00466	0.00481	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—EP300—conduct disorder	0.00454	0.00469	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—conduct disorder	0.00417	0.00431	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of Androgen receptor activity—EP300—conduct disorder	0.00413	0.00426	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00406	0.00419	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00403	0.00416	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—EP300—conduct disorder	0.00383	0.00395	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXA1 transcription factor network—EP300—conduct disorder	0.00369	0.00381	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00356	0.00368	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00328	0.00339	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00328	0.00339	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of Androgen receptor activity—EP300—conduct disorder	0.00313	0.00323	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00306	0.00315	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Circadian Clock—EP300—conduct disorder	0.00304	0.00314	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.00297	0.00306	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00294	0.00303	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—EP300—conduct disorder	0.00292	0.00301	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00273	0.00282	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—EP300—conduct disorder	0.00273	0.00281	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00267	0.00276	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—EP300—conduct disorder	0.00255	0.00263	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—EP300—conduct disorder	0.00251	0.00259	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00249	0.00257	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CGA—conduct disorder	0.00237	0.00244	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—POLR3A—conduct disorder	0.00229	0.00236	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00226	0.00234	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00223	0.0023	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—conduct disorder	0.00221	0.00228	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—COMT—conduct disorder	0.00216	0.00223	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—MAOA—conduct disorder	0.00215	0.00222	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00208	0.00215	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CGA—conduct disorder	0.00198	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00179	0.00184	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00176	0.00182	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00176	0.00181	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00174	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—POLR3A—conduct disorder	0.00174	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00174	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00173	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—WASF1—conduct disorder	0.00159	0.00164	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CGA—conduct disorder	0.00156	0.00161	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00149	0.00154	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00148	0.00153	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00143	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00142	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00141	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00138	0.00142	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—POLR3A—conduct disorder	0.00134	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—POLR3A—conduct disorder	0.00132	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00132	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—WASF1—conduct disorder	0.00125	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00122	0.00125	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00114	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—DRD4—conduct disorder	0.00111	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—COMT—conduct disorder	0.00107	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—MAOA—conduct disorder	0.00106	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00103	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000942	0.000973	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000936	0.000966	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00093	0.000959	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—EP300—conduct disorder	0.000927	0.000957	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CGA—conduct disorder	0.000916	0.000945	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—DRD4—conduct disorder	0.000874	0.000902	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—WASF1—conduct disorder	0.000734	0.000757	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR2A—conduct disorder	0.000723	0.000746	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CGA—conduct disorder	0.000665	0.000686	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR2A—conduct disorder	0.00057	0.000588	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EP300—conduct disorder	0.000547	0.000564	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CGA—conduct disorder	0.000541	0.000559	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DRD4—conduct disorder	0.000513	0.000529	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—EP300—conduct disorder	0.000458	0.000473	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EP300—conduct disorder	0.000383	0.000395	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CGA—conduct disorder	0.000357	0.000368	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2A—conduct disorder	0.000335	0.000345	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EP300—conduct disorder	0.000302	0.000312	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—COMT—conduct disorder	0.0003	0.00031	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MAOA—conduct disorder	0.000298	0.000308	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000289	0.000298	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—COMT—conduct disorder	0.000244	0.000252	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MAOA—conduct disorder	0.000243	0.00025	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000235	0.000243	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EP300—conduct disorder	0.000177	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—COMT—conduct disorder	0.000161	0.000166	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MAOA—conduct disorder	0.00016	0.000165	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—EP300—conduct disorder	0.000129	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—EP300—conduct disorder	0.000105	0.000108	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—EP300—conduct disorder	6.91e-05	7.13e-05	CbGpPWpGaD
